866-997-4948(US-Canada Toll Free)

EMEA (Europe, Middle East and Africa) Bio-pharma Market Report 2017

Published By :

QYResearch

Published Date : May 2017

Category :

Pharmaceutical

No. of Pages : 110 Pages

In this report, the EMEA Bio-pharma market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Bio-pharma for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Bio-pharma market competition by top manufacturers/players, with Bio-pharma sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
Pfizer
F. Hoffmann-La Roche AG
Johnson & Johnson Services
Sanofi, Amgen
AbbVie
Merck & Co., Inc
Biogen Idec
Bayer AG
Eli Lilly and Company
Novartis AG GlaxoSmithKline Plc
Bristol-Myers Squibb Company
AstraZeneca PLC
Abbott Laboratories

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into
Monoclonal Antibodies
Recombinant Proteins
Granulocyte-Colony Stimulating Factor (G-CSF)
Interferons
Recombinant Human Insulin
Erythropoietin
Vaccines
Growth Hormones
Purified Proteins
Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Pcs), market share and growth rate of Bio-pharma for each application, including
Metabolic Disorders
Oncology
Neurological Disorders
Cardiovascular Diseases
Inflammatory and Infectious Diseases
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

EMEA (Europe, Middle East and Africa) Bio-pharma Market Report 2017
1 Bio-pharma Overview
1.1 Product Overview and Scope of Bio-pharma
1.2 Classification of Bio-pharma
1.2.1 EMEA Bio-pharma Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Bio-pharma Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Monoclonal Antibodies
1.2.4 Recombinant Proteins
1.2.5 Granulocyte-Colony Stimulating Factor (G-CSF)
1.2.6 Interferons
1.2.7 Recombinant Human Insulin
1.2.8 Erythropoietin
1.2.9 Vaccines
1.2.10 Growth Hormones
1.2.11 Purified Proteins
1.2.12 Others
1.3 EMEA Bio-pharma Market by Application/End Users
1.3.1 EMEA Bio-pharma Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Metabolic Disorders
1.3.3 Oncology
1.3.4 Neurological Disorders
1.3.5 Cardiovascular Diseases
1.3.6 Inflammatory and Infectious Diseases
1.3.7 Others
1.4 EMEA Bio-pharma Market by Region
1.4.1 EMEA Bio-pharma Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Bio-pharma (2012-2022)
1.5.1 EMEA Bio-pharma Sales and Growth Rate (2012-2022)
1.5.2 EMEA Bio-pharma Revenue and Growth Rate (2012-2022)

2 EMEA Bio-pharma Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Bio-pharma Market Competition by Players/Manufacturers
2.1.1 EMEA Bio-pharma Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Bio-pharma Revenue and Share by Players (2012-2017)
2.1.3 EMEA Bio-pharma Sale Price by Players (2012-2017)
2.2 EMEA Bio-pharma (Volume and Value) by Type/Product Category
2.2.1 EMEA Bio-pharma Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Bio-pharma Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Bio-pharma Sale Price by Type (2012-2017)
2.3 EMEA Bio-pharma (Volume) by Application
2.4 EMEA Bio-pharma (Volume and Value) by Region
2.4.1 EMEA Bio-pharma Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Bio-pharma Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Bio-pharma Sales Price by Region (2012-2017)

3 Europe Bio-pharma (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Bio-pharma Sales and Value (2012-2017)
3.1.1 Europe Bio-pharma Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Bio-pharma Revenue and Growth Rate (2012-2017)
3.2 Europe Bio-pharma Sales and Market Share by Type
3.3 Europe Bio-pharma Sales and Market Share by Application
3.4 Europe Bio-pharma Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Bio-pharma Sales Volume by Countries (2012-2017)
3.4.2 Europe Bio-pharma Revenue by Countries (2012-2017)
3.4.3 Germany Bio-pharma Sales and Growth Rate (2012-2017)
3.4.4 France Bio-pharma Sales and Growth Rate (2012-2017)
3.4.5 UK Bio-pharma Sales and Growth Rate (2012-2017)
3.4.6 Russia Bio-pharma Sales and Growth Rate (2012-2017)
3.4.7 Italy Bio-pharma Sales and Growth Rate (2012-2017)
3.4.8 Benelux Bio-pharma Sales and Growth Rate (2012-2017)

4 Middle East Bio-pharma (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Bio-pharma Sales and Value (2012-2017)
4.1.1 Middle East Bio-pharma Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Bio-pharma Revenue and Growth Rate (2012-2017)
4.2 Middle East Bio-pharma Sales and Market Share by Type
4.3 Middle East Bio-pharma Sales and Market Share by Application
4.4 Middle East Bio-pharma Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Bio-pharma Sales Volume by Countries (2012-2017)
4.4.2 Middle East Bio-pharma Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Bio-pharma Sales and Growth Rate (2012-2017)
4.4.4 Israel Bio-pharma Sales and Growth Rate (2012-2017)
4.4.5 UAE Bio-pharma Sales and Growth Rate (2012-2017)
4.4.6 Iran Bio-pharma Sales and Growth Rate (2012-2017)

5 Africa Bio-pharma (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Bio-pharma Sales and Value (2012-2017)
5.1.1 Africa Bio-pharma Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Bio-pharma Revenue and Growth Rate (2012-2017)
5.2 Africa Bio-pharma Sales and Market Share by Type
5.3 Africa Bio-pharma Sales and Market Share by Application
5.4 Africa Bio-pharma Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Bio-pharma Sales Volume by Countries (2012-2017)
5.4.2 Africa Bio-pharma Revenue by Countries (2012-2017)
5.4.3 South Africa Bio-pharma Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Bio-pharma Sales and Growth Rate (2012-2017)
5.4.5 Egypt Bio-pharma Sales and Growth Rate (2012-2017)
5.4.6 Algeria Bio-pharma Sales and Growth Rate (2012-2017)

6 EMEA Bio-pharma Manufacturers/Players Profiles and Sales Data
6.1 Pfizer
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Bio-pharma Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Pfizer Bio-pharma Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 F. Hoffmann-La Roche AG
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Bio-pharma Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 F. Hoffmann-La Roche AG Bio-pharma Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Johnson & Johnson Services
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Bio-pharma Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Johnson & Johnson Services Bio-pharma Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Sanofi, Amgen
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Bio-pharma Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Sanofi, Amgen Bio-pharma Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 AbbVie
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Bio-pharma Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 AbbVie Bio-pharma Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Merck & Co., Inc
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Bio-pharma Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Merck & Co., Inc Bio-pharma Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Biogen Idec
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Bio-pharma Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Biogen Idec Bio-pharma Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Bayer AG
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Bio-pharma Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Bayer AG Bio-pharma Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Eli Lilly and Company
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Bio-pharma Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Eli Lilly and Company Bio-pharma Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Novartis AG GlaxoSmithKline Plc
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Bio-pharma Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Novartis AG GlaxoSmithKline Plc Bio-pharma Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Bristol-Myers Squibb Company
6.12 AstraZeneca PLC
6.13 Abbott Laboratories

7 Bio-pharma Manufacturing Cost Analysis
7.1 Bio-pharma Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Bio-pharma

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Bio-pharma Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Bio-pharma Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Bio-pharma Market Forecast (2017-2022)
11.1 EMEA Bio-pharma Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Bio-pharma Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Bio-pharma Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Bio-pharma Price and Trend Forecast (2017-2022)
11.2 EMEA Bio-pharma Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Bio-pharma Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Bio-pharma Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Bio-pharma Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Bio-pharma Sales Forecast by Type (2017-2022)
11.7 EMEA Bio-pharma Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Bio-pharma
Figure EMEA Bio-pharma Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Bio-pharma Sales Volume Market Share by Type (Product Category) in 2016
Figure Monoclonal Antibodies Product Picture
Figure Recombinant Proteins Product Picture
Figure Granulocyte-Colony Stimulating Factor (G-CSF) Product Picture
Figure Interferons Product Picture
Figure Recombinant Human Insulin Product Picture
Figure Erythropoietin Product Picture
Figure Vaccines Product Picture
Figure Growth Hormones Product Picture
Figure Purified Proteins Product Picture
Figure Others Product Picture
Figure EMEA Bio-pharma Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Bio-pharma by Application in 2016
Figure Metabolic Disorders Examples
Table Key Downstream Customer in Metabolic Disorders
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Neurological Disorders Examples
Table Key Downstream Customer in Neurological Disorders
Figure Cardiovascular Diseases Examples
Table Key Downstream Customer in Cardiovascular Diseases
Figure Inflammatory and Infectious Diseases Examples
Table Key Downstream Customer in Inflammatory and Infectious Diseases
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Bio-pharma Market Size (Million USD) by Region (2012-2022)
Figure Europe Bio-pharma Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Bio-pharma Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Bio-pharma Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Bio-pharma Revenue (Million USD) Status and Forecast by Countries
Figure Africa Bio-pharma Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Bio-pharma Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Bio-pharma Sales Volume and Growth Rate (2012-2022)
Figure EMEA Bio-pharma Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Bio-pharma Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Bio-pharma Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Bio-pharma Sales Share by Players (2012-2017)
Figure 2016 Bio-pharma Sales Share by Players
Figure 2017 Bio-pharma Sales Share by Players
Figure EMEA Bio-pharma Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Bio-pharma Revenue (Million USD) by Players (2012-2017)
Table EMEA Bio-pharma Revenue Share by Players (2012-2017)
Table 2016 EMEA Bio-pharma Revenue Share by Players
Table 2017 EMEA Bio-pharma Revenue Share by Players
Table EMEA Bio-pharma Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Bio-pharma Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Bio-pharma Sales Share by Type (2012-2017)
Figure Sales Market Share of Bio-pharma by Type (2012-2017)
Figure EMEA Bio-pharma Sales Market Share by Type (2012-2017)
Table EMEA Bio-pharma Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Bio-pharma Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Bio-pharma by Type in 2016
Table EMEA Bio-pharma Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Bio-pharma Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Bio-pharma Sales Share by Application (2012-2017)
Figure Sales Market Share of Bio-pharma by Application (2012-2017)
Figure EMEA Bio-pharma Sales Market Share by Application in 2016
Table EMEA Bio-pharma Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Bio-pharma Sales Share by Region (2012-2017)
Figure Sales Market Share of Bio-pharma by Region (2012-2017)
Figure EMEA Bio-pharma Sales Market Share in 2016
Table EMEA Bio-pharma Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Bio-pharma Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Bio-pharma by Region (2012-2017)
Figure EMEA Bio-pharma Revenue Market Share Regions in 2016
Table EMEA Bio-pharma Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Bio-pharma Revenue and Growth Rate (2012-2017)
Table Europe Bio-pharma Sales (K Pcs) by Type (2012-2017)
Table Europe Bio-pharma Market Share by Type (2012-2017)
Figure Europe Bio-pharma Market Share by Type in 2016
Table Europe Bio-pharma Sales (K Pcs) by Application (2012-2017)
Table Europe Bio-pharma Market Share by Application (2012-2017)
Figure Europe Bio-pharma Market Share by Application in 2016
Table Europe Bio-pharma Sales (K Pcs) by Countries (2012-2017)
Table Europe Bio-pharma Sales Market Share by Countries (2012-2017)
Figure Europe Bio-pharma Sales Market Share by Countries (2012-2017)
Figure Europe Bio-pharma Sales Market Share by Countries in 2016
Table Europe Bio-pharma Revenue (Million USD) by Countries (2012-2017)
Table Europe Bio-pharma Revenue Market Share by Countries (2012-2017)
Figure Europe Bio-pharma Revenue Market Share by Countries (2012-2017)
Figure Europe Bio-pharma Revenue Market Share by Countries in 2016
Figure Germany Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Bio-pharma Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Bio-pharma Sales (K Pcs) by Type (2012-2017)
Table Middle East Bio-pharma Market Share by Type (2012-2017)
Figure Middle East Bio-pharma Market Share by Type (2012-2017)
Table Middle East Bio-pharma Sales (K Pcs) by Applications (2012-2017)
Table Middle East Bio-pharma Market Share by Applications (2012-2017)
Figure Middle East Bio-pharma Sales Market Share by Application in 2016
Table Middle East Bio-pharma Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Bio-pharma Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Bio-pharma Sales Volume Market Share by Countries in 2016
Table Middle East Bio-pharma Revenue (Million USD) by Countries (2012-2017)
Table Middle East Bio-pharma Revenue Market Share by Countries (2012-2017)
Figure Middle East Bio-pharma Revenue Market Share by Countries (2012-2017)
Figure Middle East Bio-pharma Revenue Market Share by Countries in 2016
Figure Saudi Arabia Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Bio-pharma Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Bio-pharma Sales (K Pcs) by Type (2012-2017)
Table Africa Bio-pharma Sales Market Share by Type (2012-2017)
Figure Africa Bio-pharma Sales Market Share by Type (2012-2017)
Figure Africa Bio-pharma Sales Market Share by Type in 2016
Table Africa Bio-pharma Sales (K Pcs) by Application (2012-2017)
Table Africa Bio-pharma Sales Market Share by Application (2012-2017)
Figure Africa Bio-pharma Sales Market Share by Application (2012-2017)
Table Africa Bio-pharma Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Bio-pharma Sales Market Share by Countries (2012-2017)
Figure Africa Bio-pharma Sales Market Share by Countries (2012-2017)
Figure Africa Bio-pharma Sales Market Share by Countries in 2016
Table Africa Bio-pharma Revenue (Million USD) by Countries (2012-2017)
Table Africa Bio-pharma Revenue Market Share by Countries (2012-2017)
Figure Africa Bio-pharma Revenue Market Share by Countries (2012-2017)
Figure Africa Bio-pharma Revenue Market Share by Countries in 2016
Figure South Africa Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Table Pfizer Bio-pharma Basic Information List
Table Pfizer Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Pfizer Bio-pharma Sales Market Share in EMEA (2012-2017)
Figure Pfizer Bio-pharma Revenue Market Share in EMEA (2012-2017)
Table F. Hoffmann-La Roche AG Bio-pharma Basic Information List
Table F. Hoffmann-La Roche AG Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche AG Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche AG Bio-pharma Sales Market Share in EMEA (2012-2017)
Figure F. Hoffmann-La Roche AG Bio-pharma Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson Services Bio-pharma Basic Information List
Table Johnson & Johnson Services Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson & Johnson Services Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Johnson & Johnson Services Bio-pharma Sales Market Share in EMEA (2012-2017)
Figure Johnson & Johnson Services Bio-pharma Revenue Market Share in EMEA (2012-2017)
Table Sanofi, Amgen Bio-pharma Basic Information List
Table Sanofi, Amgen Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi, Amgen Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Sanofi, Amgen Bio-pharma Sales Market Share in EMEA (2012-2017)
Figure Sanofi, Amgen Bio-pharma Revenue Market Share in EMEA (2012-2017)
Table AbbVie Bio-pharma Basic Information List
Table AbbVie Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AbbVie Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure AbbVie Bio-pharma Sales Market Share in EMEA (2012-2017)
Figure AbbVie Bio-pharma Revenue Market Share in EMEA (2012-2017)
Table Merck & Co., Inc Bio-pharma Basic Information List
Table Merck & Co., Inc Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck & Co., Inc Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Merck & Co., Inc Bio-pharma Sales Market Share in EMEA (2012-2017)
Figure Merck & Co., Inc Bio-pharma Revenue Market Share in EMEA (2012-2017)
Table Biogen Idec Bio-pharma Basic Information List
Table Biogen Idec Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biogen Idec Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Biogen Idec Bio-pharma Sales Market Share in EMEA (2012-2017)
Figure Biogen Idec Bio-pharma Revenue Market Share in EMEA (2012-2017)
Table Bayer AG Bio-pharma Basic Information List
Table Bayer AG Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayer AG Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Bayer AG Bio-pharma Sales Market Share in EMEA (2012-2017)
Figure Bayer AG Bio-pharma Revenue Market Share in EMEA (2012-2017)
Table Eli Lilly and Company Bio-pharma Basic Information List
Table Eli Lilly and Company Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eli Lilly and Company Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Eli Lilly and Company Bio-pharma Sales Market Share in EMEA (2012-2017)
Figure Eli Lilly and Company Bio-pharma Revenue Market Share in EMEA (2012-2017)
Table Novartis AG GlaxoSmithKline Plc Bio-pharma Basic Information List
Table Novartis AG GlaxoSmithKline Plc Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis AG GlaxoSmithKline Plc Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Novartis AG GlaxoSmithKline Plc Bio-pharma Sales Market Share in EMEA (2012-2017)
Figure Novartis AG GlaxoSmithKline Plc Bio-pharma Revenue Market Share in EMEA (2012-2017)
Table Bristol-Myers Squibb Company Bio-pharma Basic Information List
Table AstraZeneca PLC Bio-pharma Basic Information List
Table Abbott Laboratories Bio-pharma Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bio-pharma
Figure Manufacturing Process Analysis of Bio-pharma
Figure Bio-pharma Industrial Chain Analysis
Table Raw Materials Sources of Bio-pharma Major Manufacturers in 2016
Table Major Buyers of Bio-pharma
Table Distributors/Traders List
Figure EMEA Bio-pharma Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Bio-pharma Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Bio-pharma Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Bio-pharma Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Bio-pharma Sales Market Share Forecast by Region (2017-2022)
Table EMEA Bio-pharma Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Bio-pharma Revenue Market Share Forecast by Region (2017-2022)
Table Europe Bio-pharma Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Bio-pharma Sales Market Share Forecast by Countries (2017-2022)
Table Europe Bio-pharma Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Bio-pharma Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Bio-pharma Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Bio-pharma Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Bio-pharma Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Bio-pharma Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Bio-pharma Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Bio-pharma Sales Market Share Forecast by Countries (2017-2022)
Table Africa Bio-pharma Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Bio-pharma Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Bio-pharma Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Bio-pharma Sales Market Share Forecast by Type (2017-2022)
Table EMEA Bio-pharma Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Bio-pharma Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *